This is a firm fixed-price delivery order awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 6. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $1,497,618.80 and a period of performance through December 31, 2025. This delivery order is part of a larger Indefinite Delivery, Indefinite Quantity (IDIQ) contract vehicle, and the agency has not set aside the award for small businesses. Lantheus Holdings and its subsidiaries hold several Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency to facilitate the ongoing procurement of PYLARIFY and other radiopharmaceuticals for federal healthcare programs.
Generated 12/31/24, 2:11 PM